Crossmark

Prevalence of the potential drug–drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain

Crossref DOI link: https://doi.org/10.1016/j.gastre.2019.09.001

Published Print: 2019-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sicras Mainar, Antoni

Navarro Artieda, Ruth

Hernández, Ignacio

Morillo, Ramón
Funding

Funding for this research was provided by:

Gilead Sciences
License Information

Text and Data Mining valid from 2019-10-01
More Information

This article is maintained by: Elsevier

Article Title: Prevalence of the potential drug–drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2019.09.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2019.03.014

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below